ARFFX
Price
$16.75
Change
-$0.11 (-0.65%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

ARFFX vs VMVAX

Header iconARFFX vs VMVAX Comparison
Open Charts ARFFX vs VMVAXBanner chart's image
Ariel Focus Investor
Price$16.75
Change-$0.11 (-0.65%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
ARFFX vs VMVAX Comparison Chart
Loading...
VS
ARFFX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARFFX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. ARFFX (68.1M). VMVAX pays higher dividends than ARFFX: VMVAX (2.14) vs ARFFX (1.40). ARFFX was incepted earlier than VMVAX: ARFFX (19 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. ARFFX (17.00). ARFFX has a lower initial minimum investment than VMVAX: ARFFX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. ARFFX (23.70). VMVAX return over 5 years is better than : 48.82 vs. ARFFX (35.04).
ARFFXVMVAXARFFX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years13 years-
Gain YTD14.56914.94697%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets68.1M30.5B0%
Annual Yield % from dividends1.402.1465%
Returns for 1 year23.7025.3594%
Returns for 3 years6.0820.7129%
Returns for 5 years35.0448.8272%
Returns for 10 years19.94100.8820%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio